HSP90 and HSP7Chaperone Proteins and Interactors in Cellular Signal Transduction
细胞信号转导中的 HSP90 和 HSP7 伴侣蛋白和相互作用物
基本信息
- 批准号:10926578
- 负责人:
- 金额:$ 89.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAlternative SplicingAndrogen ReceptorAndrogensAntsAreaBindingCarbonCastrationCellsCitric Acid CycleClientComplexDependenceDevelopmentElectron TransportGenetic TranscriptionGlutamineHSF1Heat-Shock Proteins 90Homologous GeneIn VitroKnock-outLengthLigand Binding DomainMagnetic Resonance SpectroscopyMalignant NeoplasmsMalignant neoplasm of prostateMalignant neoplasm of urinary bladderMediatingMetabolicMitochondriaMitochondrial ProteinsMolecular ChaperonesNeoplasm MetastasisOutcomeOxidative PhosphorylationPhenocopyPhosphotransferasesProductionProstateProteinsPyruvateRNA SplicingRegulationRenal carcinomaReproducibilityResearchResidual stateResistanceRespirationRoleSignal TransductionSourceTranslationsUrologic Diseasescancer sitecastration resistant prostate cancerdrug developmentenzalutamidein vivoinhibitormagnetic resonance spectroscopic imagingmonomernon-invasive imagingnovelnovel strategiespreference
项目摘要
We confirmed that alternatively spliced androgen receptor (lacking ligand binding domain with which Hsp90 interacts) interacts with and remains dependent on Hsp40 and Hsp70 for stability and transcriptional activity. Further, we showed that targeting the Hsp40/Hsp70 chaperone axis is a novel strategy to treat castration-resistant prostate cancer that has become resistant to standard ant-iandrogen therapy. (2) We identified a multichaperone complex in mitochondria comprised of Trap1, Hsp60 and mitochondrial Hsp70 as a regulator of oxidative phosphorylation and ATP synthase-mediated ATP production. Assembly of the multichaperone complex is sensitive to mitochondrial ATP level. We identified multiple subunits of ATP synthase and numerous electron transport chain components as Trap1 interactors (potential clients), and we demonstrated that Trap1 knockout leads to increased oxidative phosphorylation and a strong preference for glutamine as the primary carbon source for the TCA cycle. (3) We also demonstrated that Hsp70 inhibition blocked both heat-induced and Hsp90 inhibitor-potentiated HSF1 activation and transcriptional activity by causing the destabilization of HSF1. We showed that Hsp70 bound to both HSF1 monomers (inactive) and trimers (active). confirmed in vitro and in vivo activity of Hsp70 inhibitor on castrate resistant prostate, but demonstrated an early and profound effect on mitochondrial protein translation which leads to disruption of electron transport chain (ETC) complex I, with resultant collapse of the ETC. This outcome is phenocopied by a specific inhibitor of complex I. In both cases, disruption of mitochondrial respiration restores sensitivity to enzalutamide as long as residual wild type androgen is present. In vitro effects are reproducible in vivo and can be non-invasively imaged with hyperpolarized pyruvate MR spectroscopy (HP-MRSI).
我们证实,选择性剪接雄激素受体(缺乏与Hsp90相互作用的配体结合结构域)与Hsp40和Hsp70相互作用,并保持依赖于Hsp40和Hsp70的稳定性和转录活性。此外,我们表明,靶向Hsp40/Hsp70伴侣轴是治疗对标准抗雄激素疗法具有抗性的去势抵抗性前列腺癌的新策略。(2)我们确定了一个多分子伴侣复合物组成的Trap1,热休克蛋白60和线粒体热休克蛋白70作为氧化磷酸化和ATP酶介导的ATP生产的调节剂。多伴侣复合物的组装对线粒体ATP水平敏感。我们确定了ATP合酶的多个亚基和许多电子传递链组件作为Trap1相互作用物(潜在客户),我们证明了Trap1敲除导致氧化磷酸化增加和对谷氨酰胺作为TCA循环的主要碳源的强烈偏好。(3)我们还表明,热休克蛋白70抑制阻断热诱导和热休克蛋白90的增强HSF1的激活和转录活性引起的不稳定的HSF1。我们发现,Hsp70结合HSF1单体(无活性)和三聚体(活性)。证实了Hsp70抑制剂对去势抵抗性前列腺的体外和体内活性,但证明了对线粒体蛋白翻译的早期和深远的影响,这导致电子传递链(ETC)复合物I的破坏,从而导致ETC的崩溃。在这两种情况下,只要存在残留的野生型雄激素,线粒体呼吸破坏就会恢复对Enzalutamide的敏感性。体外效应在体内是可重现的,并且可以用超极化丙酮酸盐MR光谱(HP-MRSI)进行非侵入性成像。
项目成果
期刊论文数量(66)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The therapeutic target Hsp90 and cancer hallmarks.
治疗靶标 Hsp90 和癌症标志。
- DOI:10.2174/138161213804143725
- 发表时间:2013
- 期刊:
- 影响因子:3.1
- 作者:Miyata Y;Nakamoto H;Neckers L
- 通讯作者:Neckers L
Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
- DOI:10.1371/journal.pone.0141786
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Prince TL;Kijima T;Tatokoro M;Lee S;Tsutsumi S;Yim K;Rivas C;Alarcon S;Schwartz H;Khamit-Kush K;Scroggins BT;Beebe K;Trepel JB;Neckers L
- 通讯作者:Neckers L
Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
- DOI:
- 发表时间:2009-03
- 期刊:
- 影响因子:2
- 作者:F. Koga;K. Kihara;L. Neckers
- 通讯作者:F. Koga;K. Kihara;L. Neckers
Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity.
- DOI:10.4155/fmc.13.88
- 发表时间:2013-06
- 期刊:
- 影响因子:4.2
- 作者:Walton-Diaz A;Khan S;Bourboulia D;Trepel JB;Neckers L;Mollapour M
- 通讯作者:Mollapour M
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.
- DOI:10.1016/j.chembiol.2013.08.004
- 发表时间:2013-09-19
- 期刊:
- 影响因子:0
- 作者:Barrott JJ;Hughes PF;Osada T;Yang XY;Hartman ZC;Loiselle DR;Spector NL;Neckers L;Rajaram N;Hu F;Ramanujam N;Vaidyanathan G;Zalutsky MR;Lyerly HK;Haystead TA
- 通讯作者:Haystead TA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leonard Neckers其他文献
Leonard Neckers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leonard Neckers', 18)}}的其他基金
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
HSP90 家族伴侣蛋白在细胞信号转导中的作用
- 批准号:
8554037 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Post-translational modifications of Hsp90 that impact drug efficacy
影响药物疗效的 Hsp90 翻译后修饰
- 批准号:
8937930 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Role of FH loss in development of HLRCC heriditary kidney cancer
FH 缺失在 HLRCC 遗传性肾癌发展中的作用
- 批准号:
9556337 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Role of FH loss in development of HLRCC heriditary kidney cancer
FH 缺失在 HLRCC 遗传性肾癌发展中的作用
- 批准号:
8937805 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Role of FH loss in development of HLRCC heriditary kidney cancer
FH 缺失在 HLRCC 遗传性肾癌发展中的作用
- 批准号:
8763176 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
HSP90 家族伴侣蛋白在细胞信号转导中的作用
- 批准号:
8763699 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Role of FH loss in development of HLRCC heriditary kidney cancer
FH 缺失在 HLRCC 遗传性肾癌发展中的作用
- 批准号:
10702394 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
Post-translational modifications of Hsp90 that impact drug efficacy
影响药物疗效的 Hsp90 翻译后修饰
- 批准号:
7733431 - 财政年份:
- 资助金额:
$ 89.78万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Operating Grants
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 89.78万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 89.78万 - 项目类别:
Research Grants